Lynparza (olaparib) for the Treatment of BRCA-mutated Advanced Ovarian Cancer
Lynparza® (olaparib) is a targeted therapy indicated for the treatment of adults with advanced ovarian cancer, deleterious or suspected deleterious germline BRCA mutated (gBRCAm) HER2-negative high-risk early breast cancer, pancreatic cancer and prostate …